PAVmed (PAVM) Stock Statistics & Valuation Metrics

PAVmed has a market cap or net worth of $10.03M. The enterprise value is $6.55B.

PAVmed has 17,294,619 shares outstanding. The number of shares has decreased by -2.65% in one year.

PAVmed’s return on equity (ROE) is -0.02 and return on invested capital (ROIC) is 0.13%.

The current PE Ratio of PAVmed is 0.15. PAVmed’s PEG ratio is <0.01.

In the last 12 months, PAVmed had revenue of 3.00M and earned 39.79M in profits. Earnings per share was 3.30.

In the last 12 months, operating cash flow was -1.60B and capital expenditures -13.00K, giving a free cash flow of -1.60B billion.

PAVmed pays an annual dividend of $0.551, resulting in a dividend yield of ―

PAVmed upcoming earnings date is Aug 19, 2025, TBA Not Confirmed.

PAVmed as a current ratio of 0.06, with Debt / Equity ratio of 20.53%

In the past 12 months, PAVmed has paid 0.00 in taxes.

PAVmed EV to EBITDA ratio is 1.24, with an EV/FCF ratio of -1.09.

PAVmed has $2.70B in cash and marketable securities with $9.24B in debt, giving a net cash position of $6.54B billion.

Gross margin is -78.02%, with operating margin of -1485.38%, and net profit margin of 1328.58%.

The average price target for PAVmed is $11.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy